Intra-Cellular Therapies, Inc. (ITCI)
Company Info
Highlights
$13.67B
-$0.87
$481.41M
$444.86M
-$87.26M
$63.30 - $128.75
$132.73
1.73%
0.30
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Intra-Cellular Therapies, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Intra-Cellular Therapies, Inc. had a return of 53.90% year-to-date (YTD) and 75.41% in the last 12 months. Over the past 10 years, Intra-Cellular Therapies, Inc. had an annualized return of 17.58%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.
ITCI
53.90%
1.61%
72.86%
75.41%
39.23%
17.58%
^GSPC (Benchmark)
4.01%
1.13%
9.82%
22.80%
12.93%
11.26%
Monthly Returns
The table below presents the monthly returns of ITCI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 52.16% | 53.90% | |||||||||||
| 2024 | -5.98% | 3.24% | -0.46% | 3.77% | -6.36% | 1.86% | 14.94% | -6.91% | -0.15% | 15.83% | 1.06% | -2.49% | 16.62% |
| 2023 | -9.45% | 2.32% | 10.44% | 14.77% | -4.46% | 6.64% | -2.34% | -10.22% | -6.18% | -4.47% | 23.33% | 16.70% | 35.34% |
| 2022 | -9.27% | 16.82% | 10.29% | -17.29% | 13.42% | -0.56% | -5.19% | -7.13% | -7.42% | -1.85% | 18.72% | -2.40% | 1.11% |
| 2021 | 1.10% | 10.20% | -4.23% | 1.47% | 14.46% | 3.58% | -15.90% | -3.29% | 12.29% | 15.53% | -6.01% | 29.30% | 64.59% |
| 2020 | -33.87% | -7.01% | -27.16% | 14.96% | 18.17% | 22.94% | -22.77% | -8.10% | 40.83% | -3.86% | -4.18% | 34.52% | -7.32% |
| 2019 | 5.71% | 13.12% | -10.57% | 8.13% | -1.37% | -0.08% | -35.67% | 2.51% | -12.73% | 23.83% | 4.97% | 253.35% | 201.23% |
| 2018 | 17.54% | 13.81% | 8.67% | -17.24% | 33.64% | -24.10% | 13.58% | 9.32% | -1.09% | -21.75% | -14.90% | -21.18% | -21.34% |
| 2017 | -4.31% | -9.63% | 24.52% | -14.95% | -25.83% | 21.17% | -6.84% | 59.46% | -14.47% | -1.20% | -0.58% | -6.58% | -4.04% |
| 2016 | -31.07% | -24.16% | -1.14% | 23.45% | 12.76% | 0.31% | 5.10% | -1.13% | -62.22% | -18.64% | 12.42% | 8.25% | -71.95% |
| 2015 | 10.03% | 27.96% | -3.90% | -14.36% | 28.36% | 21.71% | -8.92% | -7.94% | 49.46% | 19.51% | 11.45% | 0.86% | 204.76% |
| 2014 | 29.33% | -16.34% | 12.01% | -8.14% | -9.28% | 11.29% | -14.06% | -1.86% | -3.59% | 13.06% | -7.29% | 22.83% | 17.67% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 90, ITCI is among the top 10% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Intra-Cellular Therapies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Intra-Cellular Therapies, Inc. was 87.64%, occurring on Oct 1, 2019. Recovery took 619 trading sessions.
The current Intra-Cellular Therapies, Inc. drawdown is 0.05%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.64% | Nov 30, 2015 | 966 | Oct 1, 2019 | 619 | Mar 16, 2022 | 1585 |
| -36.81% | Sep 18, 2015 | 7 | Sep 28, 2015 | 43 | Nov 27, 2015 | 50 |
| -35.41% | Mar 14, 2014 | 134 | Sep 23, 2014 | 78 | Jan 14, 2015 | 212 |
| -34.95% | Apr 7, 2022 | 118 | Sep 26, 2022 | 156 | May 10, 2023 | 274 |
| -30.21% | May 11, 2023 | 119 | Oct 30, 2023 | 37 | Dec 21, 2023 | 156 |
Volatility
Volatility Chart
The current Intra-Cellular Therapies, Inc. volatility is 0.95%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Intra-Cellular Therapies, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |